Drugdiscovery >> Pharmaceutical Companies >> News
3053
Views
AstraZeneca buys anti-diabetes giant - drugdiscovery.com
AstraZeneca buys anti-diabetes giant - drugdiscovery.com


AstraZeneca PLC will buy out Bristol-Myers Squibb. This opens a new market for the anglo-swedish company to sell drugs. According to the company this helps to make diabetes drugs free and good
Read More >>


Tags: AstraZeneca,Birstol Myers Squibb, diabeters - December 22, 2013
Related Articles
4530
Views
New Contracts at Astra Zeneca New Contracts at Astra Zeneca
Astra Zeneca has started a contribution with prvately held Spirogen. The companies develop and anti-body drug together. This might be the key of financial success to both part. Read More >>

Tags: AstraZeneca, anti-body drug, contribution

4306
Views
The price of AstraZeneca 's stock increased after Pfizer's offer The price of AstraZeneca 's stock increased after Pfizer's offer
The price of AstraZeneca stocks runned up after Pfizer announced that it is willing to buy o buy the company for around $100 billion. Lately, AstraZeneca turned down another similar offer. Read More >>

Tags: Stock, pharmaceutival business, pharmaceutical companies, AstraZeneca,Pfizer, pharmaceutical stock exchange, pharma stocks, astrazeneca sold

5225
Views
What is happening with AstraZeneca. What is happening with AstraZeneca.
Pfizer announced to buy AstraZeneca many times. But what is in the backround of this diecision and what is happening with the two companies? Read More >>

Tags: Astra Zeneca, Pfizer, pharmaceutical companies, astraZeneca business.

4225
Views
AstraZeneca links with privately held company to research cancer AstraZeneca links with privately held company to research cancer
AstraZeneca has announced that its biologic development arm is going to co-operate with Immunocore Limited. This is a privately held company and works on T-cell related researches. Read More >>

Tags: T-cell, AstraZeneca, Immunocore, co-operation

1596
Views
AstraZeneca CFO to join BG AstraZeneca CFO to join BG
Simon Lowth, chief financial officer at AstraZeneca, is leaving the pharmaceutical company to take on the same role at oil and gas group BG. Read More >>

Tags: AstraZeneca,Simon Lowth

5162
Views
AstraZeneca: New Partnership in Combat Kidney Disease AstraZeneca: New Partnership in Combat Kidney Disease
Evotec AG and AstraZeneca step into fellowship to fight kidney disease. The two giants are working on finding new possibilities and components, which might modify disease and help the quick recovery o Read More >>

Tags: contrect, Evotec AG, AstraZeneca, kidney

4289
Views
AstraZeneca and Pfizer merger: Do cancer patients loose? AstraZeneca and Pfizer merger: Do cancer patients loose?
Even the most-sold drug of Pfizer was an aquisition. therefore, expert predict that the company can only survive if it merges with others. Read More >>

Tags: pfizer, astrazeneca, pfizer merge, astra zeneca aquisition

4855
Views
AstraZeneca pleased with quarter despite profits fall AstraZeneca pleased with quarter despite profits fall
Patent expiries continue to hurt sales and earnings Read More >>

Tags: AstraZeneca, profits

1702
Views
Actavis buys Warner Chilcott Actavis buys Warner Chilcott
Shareholders of Actavis and Ireland-based Warner Chilcott have approved the deal which will make the new Actavis the third-largest specialty pharmaceutical company in the U.S. market. The deal is ex Read More >>

Tags: Actavis, Warner Chilcott, deal, purchase

4865
Views
AstraZeneca - Hadasit alliance AstraZeneca - Hadasit alliance
AstraZeneca and Hadasit have made a collaboration agreement on novel drug discovery across a broad range of diseases , with a primary focus on cancer, respiratory diseases and diabetes. Read More >>

Tags: AstraZeneca, Hadasit, alliance, collaboration

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013